珍宝岛: 黑龙江珍宝岛药业股份有限公司第五届监事会第十八次会议决议公告

Core Points - The company held its 18th meeting of the 5th Supervisory Board on May 13, 2025, where it approved the use of idle raised funds to temporarily supplement working capital [1][2] - The Supervisory Board concluded that the approval process for using up to RMB 300 million of idle raised funds complies with relevant laws and regulations, does not change the purpose of the raised funds, and does not harm shareholder interests [1][2] Summary by Sections Meeting Details - The meeting was conducted in person at the company's conference room with three supervisors present, chaired by Mr. Lan Peibao [1] Resolution Passed - The resolution to use idle raised funds was unanimously approved by the Supervisory Board with three votes in favor and no votes against or abstentions [2]